학술논문

Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.
Document Type
Article
Source
NPJ Precision Oncology; 2/6/2024, Vol. 8 Issue 1, p1-13, 13p
Subject
PANCREATIC duct
RAS oncogenes
TREATMENT effectiveness
PANCREATIC enzymes
GENETIC mutation
ADENOCARCINOMA
PANCREATIC intraepithelial neoplasia
Language
ISSN
2397768X
Abstract
Copyright of NPJ Precision Oncology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)